| # | Drug | Count |
|---|---|---|
| 0 | MACITENTAN | 917 |
| 1 | VENETOCLAX | 857 |
| 2 | FUROSEMIDE | 815 |
| 3 | ECULIZUMAB | 709 |
| 4 | SILDENAFIL CITRATE | 598 |
| 5 | BOSENTAN | 539 |
| 6 | ASPIRIN | 504 |
| 7 | TADALAFIL | 491 |
| 8 | ASPIRIN 325 MG | 471 |
| 9 | ASPIRIN 81 MG | 471 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEDAZURIDINE AND DECITABINE | 69 | 0.0789 |
| 1 | LEUCINE, PHENYLALANINE, LYSINE HYDROCHLORIDE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, TYROSINE, SERINE | 4 | 0.0635 |
| 2 | OLUTASIDENIB | 12 | 0.0436 |
| 3 | PACRITINIB | 84 | 0.0283 |
| 4 | REVUMENIB | 18 | 0.0205 |
| 5 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 49 | 0.0177 |
| 6 | EPOPROSTENOL | 193 | 0.0148 |
| 7 | PENTAMIDINE ISETHIONATE | 18 | 0.0146 |
| 8 | VENETOCLAX | 857 | 0.0140 |
| 9 | MACITENTAN | 917 | 0.0133 |
| # | Drug class | Count |
|---|---|---|
| 0 | Endothelin Receptor Antagonist [EPC] | 1351 |
| 1 | Loop Diuretic [EPC] | 933 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 924 |
| 3 | BCL-2 Inhibitor [EPC] | 857 |
| 4 | Corticosteroid [EPC] | 814 |
| 5 | Phosphodiesterase 5 Inhibitor [EPC] | 755 |
| 6 | Complement Inhibitor [EPC] | 742 |
| 7 | Kinase Inhibitor [EPC] | 542 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 518 |
| 9 | Prostacycline Vasodilator [EPC] | 475 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | BCL-2 Inhibitor [EPC] | 857 | 0.0140 |
| 1 | Prostacyclin Receptor Agonist [EPC] | 329 | 0.0128 |
| 2 | Complement Inhibitor [EPC] | 742 | 0.0108 |
| 3 | Complement C5 Inhibitor [EPC] | 1 | 0.0108 |
| 4 | Soluble Guanylate Cyclase Stimulator [EPC] | 279 | 0.0084 |
| 5 | Endothelin Receptor Antagonist [EPC] | 1351 | 0.0068 |
| 6 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 20 | 0.0064 |
| 7 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 13 | 0.0063 |
| 8 | Phosphodiesterase 5 Inhibitor [EPC] | 755 | 0.0057 |
| 9 | Prostacycline [EPC] | 5 | 0.0054 |